Edap Tms SA

EDAP08 Dec 2024
Healthcare
$2.27
-0.06 (-5.82%)
Lowest Today
$2.14
Highest Today
$2.33
Today’s Open
$2.27
Prev. Close
$2.32
52 Week High
$8.5
52 Week Low
$2.14
To Invest in Edap Tms SA

Edap Tms SA

Healthcare
EDAP08 Dec 2024
-0.06 (-5.82%)
1M
3M
6M
1Y
5Y
Low
$2.14
Day’s Range
High
$2.33
2.14
52 Week Low
$2.14
52-Week Range
52 Week High
$8.5
2.14
1 Day
-
1 Week
-6.99%
1 month return
-9.23%
3 month return
-23.38%
6 month return
-57.35%
1 Year return
-56.37%
3 Years return
-58.75%
5 Years return
-53.11%
10 Years return
-
Institutional Holdings
Soleus Capital Management, L.P.
19.7
Morgan Stanley - Brokerage Accounts
9.08
Rock Springs Capital Management LP
4.23
Archon Capital Management LLC
2.86
Bruce & Co Inc
1.49
Apis Capital Advisors, LLC
1.46
Bruce
1.43

Market Status

Fundamentals
Market Cap
81.07 mln
PB Ratio
1.8
PE Ratio
0
Enterprise Value
60.38 mln
Total Assets
91.55 mln
Volume

Company Financials

Fund house & investment objective

Company Information
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.
Organisation
Edap Tms SA
Employees
307
Industry
Medical Distribution
CEO
Mr. Ryan  Rhodes
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities